SEC Form 4Coverage since Aug 7, 2026
$BRVE insider trading
Over the last 12 months, Braveheart Bio insiders reported 8 buys totaling $69.4M and no sales across SEC Form 4 filings.
- Bought · 12m
- $69.4M 8 events
- Sold · 12m
- — 0 events
- Events · 12m
- 8 Form 4 filings, grouped
- Insiders · 12m
- 7 distinct reporters
- 10b5-1 share
- 0% pre-arranged plans
Side
Price · $BRVE · 12Mvia TradingView
Top insiders · 12m
Forbion Growth Opportunities Fund III Cooperatief U.A.—2× · $64.8M
Viehbacher Christopher—1× · $1.5M
Murdoch TravisCEO and President1× · $1.5M
Lubner David Charles—1× · $1000K
Rickey James PaulChief Financial Officer1× · $500K
All insider trades
8 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | Forbion Growth Opportunities Fund III Cooperatief U.A.10% | ▲ Buy | 1,680,000 | $18 | $30.2M | +19.8% | indirect |
| Aug 7, 2026 | Forbion Growth Opportunities Fund III Cooperatief U.A.10% | ▲ Buy | 1,920,000 | $18 | $34.6M | +19.8% | — |
| Aug 7, 2026 | Rickey James PaulChief Financial Officer · O | ▲ Buy | 27,777 | $18 | $500K | +5.6% | — |
| Aug 7, 2026 | Viehbacher ChristopherD | ▲ Buy | 83,333 | $18 | $1.5M | +15.8% | — |
| Aug 7, 2026 | Malek David ID | ▲ Buy | 4,166 | $18 | $75K | +0.8% | — |
| Aug 7, 2026 | Anderson Michele A.Chief Development Officer · O | ▲ Buy | 1,111 | $18 | $20K | +0.3% | — |
| Aug 7, 2026 | Murdoch TravisCEO and President · O·D | ▲ Buy | 83,333 | $18 | $1.5M | +2.9% | — |
| Aug 7, 2026 | Lubner David CharlesD | ▲ Buy | 55,555 | $18 | $1000K | — | — |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $BRVE feed.